Curbing the global aids epidemic

New England Journal of Medicine

Volumn 348, Issue 18, 2003, Pages 1802-1805

  Gayle, Helene D ^a  

^a BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BUDGET; DEVELOPING COUNTRY; EPIDEMIC; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE POLICY; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LABORATORY TEST; MONEY; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RESOURCE ALLOCATION; SECONDARY PREVENTION; SHORT SURVEY; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; DISEASE OUTBREAKS; HEALTH BEHAVIOR; HEALTH EXPENDITURES; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; WORLD HEALTH;

EID: 0037408420     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMsb030352     Document Type: Short Survey

References (15)

1. Stover J, Walker N, Garnett GP, et al. Can we reverse the HIV/ AIDS pandemic with an expanded response? Lancet 2002;360:73-7.
2. National Intelligence Council. The next wave of HIV/AIDS: Nigeria, Ethiopia, Russia, India, and China. Washington, D.C.: Central Intelligence Agency, September 2002. (NIC publication no. ICA 2002-04D.)
3. Jha P, Mills A, Hanson K, et al. Improving the health of the global poor. Science 2002;295:2036-9.
4. Report to the Programme Coordinating Board of UNAIDS: financial resources for HIV/AIDS programmes in low- and middle-income countries over the next five years, November 2002. Geneva: UNAIDS, 2002. (Accessed March 24, 2003, at http://www.unaids. org/about/governance/governance.html#pcb-meet.)
5. Global mobilization for HIV prevention: a blueprint for action. Global HIV Prevention Working Group, 2002.
6. The Voluntary HIV-1 Counseling and Testing Efficacy Study Group. Efficacy of voluntary HIV:1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial. Lancet 2000;356:103-12.
7. Ford K, Wirawan DN, Fajans P, Meliawan P, MacDonald K, Thorpe L. Behavioral interventions for reduction of sexually transmitted disease/HIV transmission among female commercial sex workers and clients in Bali, Indonesia. AIDS 1996;10:213-22.
8. Grosskuth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995;346:530-6.
9. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999;354:795-802.
10. Des Jarlais DC, Hagan H, Friedman SR, et al. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA 1995;274:1226-31.
11. Scaling up antiretroviral therapy in resource-limited settings: guidelines for a public health approach. Geneva: World Health Organization, June 2002.
12. Gray RH, Wawer MJ, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001;357:1149-53.
13. Blower S. Calculating the consequences: HAART and risky sex. AIDS 2001;15:1309-10.
14. Van de Ven P, Kippax S, Knox S, Prestage G, Crawford J. HIV treatments optimism and sexual behaviour among gay men in Sydney and Melbourne. AIDS 1999;13:2289-94.
15. Report on the global HIV/AIDS epidemic. Geneva: UNAIDS, July 2002.